Search research articles
Contact Us
Filters
Showing results (461-470 of 618) with videos related to
Page
of 62
Sort By:
Agro Food Industry Hi-Tech
|
May 6, 2011
Iron: A Pathological Mediator of Alzheimer Disease?
Raj K Rolston, George Perry, Xiongwei Zhu, et al.
Acta Neurobiologiae Experimentalis
|
June 12, 2004
The role of metabotropic glutamate receptors in Alzheimer's disease
Hyoung-Gon Lee, Xiongwei Zhu, Michael J O'Neill, et al.
Trends in Molecular Medicine
|
April 13, 2005
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
Hyoung-Gon Lee, George Perry, Paula I Moreira, et al.
Plant Physiology
|
November 24, 2012
Involvement of Arabidopsis ACYL-COENZYME A DESATURASE-LIKE2 (At2g31360) in the biosynthesis of the very-long-chain monounsaturated fatty acid components of membrane lipids
Mark A Smith, Melanie Dauk, Hussein Ramadan, et al.
Current Alzheimer Research
|
October 16, 2012
Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease
Sónia C Correia, Renato X Santos, Maria S Santos, et al.
Journal of Neuroscience Research
|
October 23, 2002
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology
Richard L Bowen, Mark A Smith, Peggy L R Harris, et al.
Human Molecular Genetics
|
November 22, 2011
Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death
Wataru Kudo, Hyun-Pil Lee, Wen-Quan Zou, et al.
Current Medicinal Chemistry
|
May 17, 2005
Therapeutic opportunities in Alzheimer disease: one for all or all for one?
Michael W Marlatt, Kate M Webber, Paula I Moreira, et al.
Neurobiology of Aging
|
October 11, 2011
Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease
Jaewon Chang, Agnes Rimando, Merce Pallas, et al.
Journal of Neuropathology and Experimental Neurology
|
February 10, 2012
The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons
Akihiko Nunomura, Toshio Tamaoki, Nobutaka Motohashi, et al.
Page
of 62
Search research articles
Search
Showing results (461-470 of 618) with videos related to
Sort By:
Page
of 62
Agro Food Industry Hi-Tech
|
May 6, 2011
Iron: A Pathological Mediator of Alzheimer Disease?
Raj K Rolston, George Perry, Xiongwei Zhu, et al.
Acta Neurobiologiae Experimentalis
|
June 12, 2004
The role of metabotropic glutamate receptors in Alzheimer's disease
Hyoung-Gon Lee, Xiongwei Zhu, Michael J O'Neill, et al.
Trends in Molecular Medicine
|
April 13, 2005
Tau phosphorylation in Alzheimer's disease: pathogen or protector?
Hyoung-Gon Lee, George Perry, Paula I Moreira, et al.
Plant Physiology
|
November 24, 2012
Involvement of Arabidopsis ACYL-COENZYME A DESATURASE-LIKE2 (At2g31360) in the biosynthesis of the very-long-chain monounsaturated fatty acid components of membrane lipids
Mark A Smith, Melanie Dauk, Hussein Ramadan, et al.
Current Alzheimer Research
|
October 16, 2012
Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease
Sónia C Correia, Renato X Santos, Maria S Santos, et al.
Journal of Neuroscience Research
|
October 23, 2002
Elevated luteinizing hormone expression colocalizes with neurons vulnerable to Alzheimer's disease pathology
Richard L Bowen, Mark A Smith, Peggy L R Harris, et al.
Human Molecular Genetics
|
November 22, 2011
Cellular prion protein is essential for oligomeric amyloid-β-induced neuronal cell death
Wataru Kudo, Hyun-Pil Lee, Wen-Quan Zou, et al.
Current Medicinal Chemistry
|
May 17, 2005
Therapeutic opportunities in Alzheimer disease: one for all or all for one?
Michael W Marlatt, Kate M Webber, Paula I Moreira, et al.
Neurobiology of Aging
|
October 11, 2011
Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease
Jaewon Chang, Agnes Rimando, Merce Pallas, et al.
Journal of Neuropathology and Experimental Neurology
|
February 10, 2012
The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons
Akihiko Nunomura, Toshio Tamaoki, Nobutaka Motohashi, et al.
Page
of 62